Abstract
According to this report, the $1.2 billion 2008 global market for products
used to monitor and treat neonatal and perinatal patients will grow at a CAGR
of 5.2% reaching over $1.5 billion by 2013.
Growth in Asia-Pacific and other international markets will be driven by
expanding populations and increasing birth rates, greater demand for these
products, and the growing availability of low-cost or locally manufactured
technologies. Developing countries account for the vast majority of annual
births and preterm infants, which are at risk for developing conditions
requiring ventilation, warming therapy, jaundice management, and neonatal
monitoring. Driven by a growing middle class, demand is increasing for these
products, which are well-established in the developed markets of the U.S.,
Western Europe, and Japan. The growing availability of low-cost and locally
manufactured products will continue to drive sales of new units in these
countries.
Sales growth will be relatively flat in the U.S. and Europe through 2013.
Revenues will be driven by replacement technologies and accessories, and
hospitals will continue to prefer devices that offer multiple functions. In
infant ventilation, sales will increasingly shift towards comprehensive units
capable of treating a full range of patients including neonatal, pediatric,
and adult patients. Hybrid warming devices that can be configured as either
open warmers or closed incubators will also be preferred. Specialty products
such as high-frequency ventilators will also see strong sales growth through
2013. Homecare will represent a growing source for sales of monitoring and
jaundice management products.
This report includes coverage of infant ventilation, infant warming, jaundice
management, and monitoring products in the U.S., European, Asia-Pacific, and
Rest-of-World (ROW) markets. Featured companies include Atom Medical, Draeger
Medical, Fisher & Paykel Healthcare, GE Healthcare, Maquet (Getinge),
Respironics (Philips Healthcare), Spacelabs Healthcare (OSI Systems), and
Viasys (Cardinal Health), amongst others.
|